Clinical Research Facility
Woburn, Massachusetts 01801
We've found
1 trials
at this facility
Human Papillomavirus Infection Clinical Trial
Updated: 4/18/2014
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials